Experimental cell therapy injected into spine to fight advanced brain cancer
NCT ID NCT06592092
Summary
This small, early-stage study tested a new cell therapy called QH104 for patients with advanced solid tumors that had spread to the lining of the brain and spinal cord. The therapy involved injecting specially engineered immune cells directly into the spinal fluid to try to attack the cancer. The main goal was to see if this approach was safe and showed any signs of helping 3-6 very sick patients who had run out of standard treatment options.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, 100021, China
Conditions
Explore the condition pages connected to this study.